GlassScriptPhysician profile
Michael J Jenson
NPI 1841724291
$6,879.98
in general payments reported to CMS, 2019-2025
30 companies · $3,903 in 2025
The $3,903 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,464 · 2022: $499 · 2023: $559 · 2024: $455 · 2025: $3,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,200 · Food and Beverage: $1,832 · Travel and Lodging: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,200.00 |
| Food and Beverage | $1,831.78 |
| Travel and Lodging | $884.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $3,424.90 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $1,404.13 | 2021-2022 | |
| Coloplast Corp | $343.97 | 2023-2025 | Speedicath |
| Boston Scientific Corporation | $325.03 | 2022-2025 | Rezum Generator, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Teleflex LLC | $301.05 | 2022-2025 | Urolift, Barrigel |
| Olympus America INC. | $127.41 | 2022 | |
| Janssen Biotech, INC. | $107.76 | 2022-2025 | Erleada, Akeega, Balversa |
| Angiodynamics, INC. | $107.61 | 2025 | Nanoknife |
| Antares Pharma, INC. | $99.53 | 2021-2024 | Xyosted |
| Convatec INC. | $72.04 | 2022-2023 | |
| Urogen Pharma, INC. | $64.93 | 2024-2025 | |
| 180 Medical, INC. | $56.33 | 2021-2025 | |
| Pfizer INC. | $49.63 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $48.71 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $43.43 | 2024-2025 | Xtandi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $42.42 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.41 | 2025 | |
| Abbvie INC. | $31.72 | 2025 | |
| Merck Sharp & Dohme LLC | $28.76 | 2024-2025 | Keytruda |
| Caris Mpi, INC. | $20.11 | 2025 | Mi Cancer Seek |
| Myovant Sciences INC. | $17.12 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $14.97 | 2022 | |
| Amgen INC. | $14.96 | 2023 | Prolia |
| Abc Home Medical Supply, INC. | $14.64 | 2025 | |
| Photocure INC | $14.47 | 2024 | Cysview |
| Medtronic, INC. | $14.40 | 2021 | |
| Sun Pharmaceutical Industries INC. | $13.97 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.63 | 2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $13.62 | 2021 | |
| Hollister Incorporated | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.